Thirty Madison uses $12.5M to launch migraine platform
NEW YORK – Digital health company Thirty Madison has raised $12.5 million in Series A funding to launch Cove, a direct-to-consumer health care company that will offer personalized treatment solutions for migraine sufferers. “We know that consumers expect more from their healthcare than they’re currently getting,” said Steven Gutentag, co-founder of Thirty Madison, in a statement. “Most young people no longer have a primary care physician, the costs of care are skyrocketing and patients are increasingly thinking like consumers—yet the health care experience has not evolved to meet any of this. We want to change that.” Cove provides a virtual consultation with a licensed physician and a personalized treatment plan, including symptom tracking. Thirty Madison will also use the Series A funds to continue growing their first brand Keeps, a digital platform for male pattern baldness. The company will launch Cove later this year.
Hero raises $12M, launches connected medication management platform
NEW YORK – Hero has raised $12 million in Series A funding and launched a new medication management platform. The automated in-home medication manager intuitively sorts and dispenses medication, has audible and digital reminders, automates refills and provides real-time and historical adherence data. “I knew there had to be a way to use technology to ease the daily burden of managing multiple medications and to provide reliable support to caregivers, while addressing some of the obstacles in place from our challenged healthcare system,” said Kal Vepuri, founder and CEO of Hero, in a statement. The Hero system includes: the Hero countertop device which automatically stores, dispenses and tracks medications; the Hero mobile app that creates and manages all medication regimens, sends notifications to caregivers regarding dispensed, skipped and additional doses, provides real-time access to drug information and tracks adherence over time; and the Hero fill service option, which prompts and manages the delivery of prescription medication, over-the-counter medication and supplements directly to the home.
With CE Mark, TytoCare launches telehealth solution in Europe
NEW YORK – Telehealth provider TytoCare has received CE Mark approval for its end-to-end telehealth solution. The clearance will allow the company to roll out the connected system, which includes an otoscope, stethoscope, camera and telehealth platform, immediately in Europe. “Receiving CE Mark approval is an important milestone for TytoCare and a major step in our continued strategic expansion into Europe and other new markets,” said Dedi Gilad, CEO and co-founder of TytoCare, in a statement. “European doctors are struggling to keep up with the increasing medical demand of an aging population and the rise of chronic illnesses. Tyto is uniquely positioned to ease this burden by replicating the quality of in-person doctor visits without any barriers to access such as transportation and wait time.” The roll out will take place through partnerships with telehealth companies, health systems and insurance providers. TytoCare received clearance from the U.S. Food and Drug Administration for its connected system in 2017. Exam data can be shared with a clinician in real-time as a live video telehealth visit or in advance of a telehealth session for a remote diagnosis.
Phillips-Medisize, InterSystems partner on connected health platform
HUDSON, Wisc. – Phillips-Medisize, a Molex company, has joined forces with health care software provider InterSystems to develop a third-generation connected health platform that enables pharmaceutical companies to connect medication and diagnostic information across their drugs and therapy areas in a single platform. The integration of InterSystems HealthShare will offer an information-sharing and analytics platform designed for connected drug delivery devices, biosensors and regulated Mobile Medical Applications (SaMD/MMA). “Our collaboration with InterSystems brings together the information that matters—connecting pharmaceutical companies, providers, patients and payers on the Phillips-Medisize Connected Health Platform—through a unified healthcare medication record and powerful analytics that span the care continuum,” said Matt Jennings, CEO and president of Phillips-Medisize, in a statement. Data collected by connected devices using the Phillips-Medisize Connected Health Platform can be shared securely to inform the patient and their health care provider when medications have been administered, and can be combined with data from diagnostic devices and biometric sensors to generate further insights. Pharmaceutical companies working with Phillips-Medisize will receive an exclusive, secure private cloud. “The collaboration between InterSystems and Phillips-Medisize aims to change the paradigm with a highly scalable platform to securely connect and aggregate data from rare diseases to many millions of patients across global geographies, encouraging patients in the most effective use of prescribed medications to improve outcomes,” said Don Woodlock, head of the HealthShare business unit at InterSystems, in a statement.
AMA launches Digital Health Playbook
BOSTON – The American Medical Association has launched a Digital Health Implementation Playbook for providers, a guide to the most efficient path for applying digital health solutions, including key steps, best practices and resources to accelerate and achieve digital health adoption. “Implementing digital health technology has been a challenge for those without a clear course to success,” said Dr. Jesse Ehrenfeld, chair-elect of the American Medical Association, in a statement. “The AMA is committed to making technology an asset, not a burden, and the Playbook provides the medical community with widespread access to a proven path for implementing digitally enabled health and care.” The Playbook is designed for care teams and administrators in medical practices of all sizes and areas of specialty, and will be updated to include new content over time. As it evolves, the Playbook will provide a 12-step process to guide the implementation of a variety of digital health solutions. Currently, the Playbook provides resources for the implementation of remote patient monitoring using devices, trackers and sensors to capture and record patient generated health data outside of the traditional clinical environment.
Universe mHealth updates app platform
DALLAS – Universe mHealth has released an updated version of its Universe mHealth App Platform, which enables health care organizations to publish their own branded mobile app with a suite of pre-built features for health summaries, appointment scheduling, messaging, urgent care wait times, physician search, patient education, bill pay and more. The new version 1.1 includes a number of performance, compatibility and compliance improvements, including the addition of family/proxy accounts, which allow a caregiver to toggle between different dependent or care receiver accounts. The caregiver can also receive SMS, email and/or mobile push notifications on behalf of the dependent or care receiver. “Parents are among the most active patient portal users,” said John Deutsch, founder and CEO of Universe mHealth, in a statement. “Providing parents with the ability to easily manage their children’s care from a mobile app is an incredibly powerful feature and was the most requested feature since the launch of version 1.0.” The Universe mHealth platform also features the ability to view imaging reports and documents, CCD-based health summaries, urgent care wait times and more.
GoFind launches crowdfunding campaign
RICHARDSON, Texas – GoFind Inc., a developer of GPS trackers, recently launched a crowdfunding campaign to develop an artificial intelligence-powered Personal Emergency Response device called NudgeR. The NudgeR device will feature fall detection, wellbeing checks, geolocation, activity detection, medication and appointment reminders, and voice alerts. “The system we are developing addresses physical, mental and social needs by combining the rapid advances in Internet of Things devices, voice assistants and AI to form a more comprehensive solution,” said Tony Valentino, COO of GoFind, in a statement. The goal is for senior users to form a bond with the NudgeR device as an extension of the family or circle of friends, and to help reduce the cost and time associated with in-home caregiver visits and postpone the need for assisted living arrangements, he said.
Self-powered sensor could help monitor surgical recovery
WATERLOO, Ontario – A self-powered sensor developed at the University of Waterloo could allow doctors to remotely monitor the recovery of surgical patients. The sensor—a small, tube-like device—is designed to be fitted to braces after joint surgery to wirelessly send information to computers, smartphones or smartwatches to track range of motion and other indicators of improvement. “That data would be continuously collected, so it would be as though the physician or physiotherapist was always there, always observing the patient,” said Hassan Askari, an engineering doctoral candidate at Waterloo, in a statement. A prototype built and tested by the researchers combines electromagnetism and triboelectricity, an energy harvesting technique that involves bringing different materials together to produce current. When bent or twisted, the device generates enough electricity for sensing and powering electronic circuits for processing and wireless signal transmission. “The aim was to develop a sensor that works without having a battery attached to it,” said Askari. “It is its own power source.”
Beddr launches Sleep Tuner wearable
MOUNTAIN VIEW, Calif. – Health technology company Beddr has launched SleepTuner, a wearable that can assess and help improve sleep quality. The device attaches to the forehead with a hypoallergenic adhesive and integrates a compact, clinical-grade sleep sensor with an iOS mobile app to provide deeper, personalized insights into the user’s sleep quality and actionable recommendations on how to improve it. SleepTuner captures clinical data and accurately measures blood oxygen, heart rate, sleep position and stopped breathing events. “The key to better sleep is breathing, and SleepTuner provides access to insights on oxygen levels that cannot be found in traditional consumer sleep trackers,” said Mike Kisch, CEO and co-founder of Beddr, in a statement. “We aim to empower anyone to figure out the cause of their poor sleep within a few days in the privacy of their own home.”In a recent study conducted at the University of California San Francisco, SleepTuner was found to be accurate with an error margin of around 2.2% when compared to an arterial blood draw.
Catalia Health’s robot to offer AHA-backed content
SAN FRANCISCO ‑ Catalia Health, a patient care management company that provides an artificial intelligence-powered patient engagement platform, has joined the American Heart Association’s Center for Health Technology & Innovation’s Innovators Network.
The network focuses on finding innovative and scalable solutions in the health care market.
Catalia Health’s platform combines AI, psychology and medical best practices to deliver support and everyday care to people managing chronic conditions.
“We’re on a mission to address both parts of the health care equation: improving patient outcomes and expanding the current capabilities and efficiency of health care companies,” said Dr. Cory Kidd, founder and CEO of Catalia Health, in a statement. “This new milestone with the American Heart Association solidifies a critical step in further enhancing our technology and expanding our reach to even more people struggling with chronic disease.”
Catalia Health will work with the AHA to deliver the Association’s scientifically-backed guidelines through Mabu, Catalia Health’s personal health care companion robot. Through active conversation, Mabu will provide comprehensive content about heart health through a guided conversational approach that is available whenever a patient requests it. Mabu is also present to answer basic questions to help educate the patient about the next best action.
Mabu also supports patients living with chronic illnesses such as congestive heart failure, rheumatoid arthritis and late-stage kidney disease, and completes daily check-ins using tailored conversations with patients to help them manage care routines, while providing insights to health care professionals about patient health, progress and adherence to treatment.
Baird partners with Texas Medical Center to develop health technology
HOUSTON – Baird Capital is partnering with Texas Medical Center to fuel an infusion of growth capital into the provider’s entrepreneurial ecosystem.
Baird Capital is the direct private investment arm of Baird, an employee-owned wealth management, capital markets, asset management and private equity firm.
“This partnership is significant as it brings deep venture expertise in health care and technology as well as access to capital to Houston,” said Bill McKeon, president and CEO of Texas Medical Center, in a statement. “Texas Medical Center is excited to welcome Baird as a key component to our growing and unprecedented life science hub. This is yet another major milestone for establishing the Texas Medical Center as the Third Coast of life sciences.”
Baird Capital will establish an office in Texas Medical Center, which has a campus that spreads out to more than 1,400 acres and houses 21 hospitals, four medical schools, six nursing schools and more than 100,000 medical professionals. Together, Baird and Texas Medical Center leadership will explore and foster investment opportunities and link directly to Baird Capital’s global platform with the ability to tap into capital and expert advisors.
“Texas Medical Center’s unique position as a leading expert in the health care and life sciences sectors will be an invaluable advantage to Baird Capital and its portfolio companies and will serve as a significant asset in Baird’s continued growth and success,” said Steve Booth, president and CEO of Baird, in a statement. This partnership will provide a number of compelling opportunities for Baird Capital and TMC to share expertise and resources.”